XML 20 R6.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended 12 Months Ended
Jul. 31, 2021
Aug. 01, 2020
Jul. 31, 2021
Aug. 01, 2020
Jan. 30, 2021
Operating activities          
Net loss     $ (12,212) $ (63,240)  
Add (deduct) items not affecting operating cash flows:          
Adjustment to Tax Receivable Agreement Liability       (2,320)  
Impairment of goodwill and intangible assets       13,848 $ 13,848
Impairment of long-lived assets       13,026  
Depreciation and amortization     3,119 3,654  
Provision for bad debt     (100) 2,001  
Amortization of deferred financing costs     401 277  
Deferred income taxes     3,872 102  
Share-based compensation expense $ 558 $ 525 889 1,066  
Capitalized PIK Interest     1,257    
Changes in assets and liabilities:          
Receivables, net     821 20,067  
Inventories     (6,101) (25,740)  
Prepaid expenses and other current assets     1,459 3,135  
Accounts payable and accrued expenses     7,893 11,775  
Other assets and liabilities     (1,588) 1,097  
Net cash used in operating activities     (290) (21,252)  
Investing activities          
Payments for capital expenditures     (1,919) (1,597)  
Net cash used in investing activities     (1,919) (1,597)  
Financing activities          
Proceeds from borrowings under the Revolving Credit Facilities     137,739 106,048  
Repayment of borrowings under the Revolving Credit Facilities     (137,554) (82,548)  
Tax withholdings related to restricted stock vesting     (62) (222)  
Proceeds from stock option exercises, restricted stock vesting, and issuance of common stock under employee stock purchase plan     72 24  
Financing fees     (288) (225)  
Net cash (used in) provided by financing activities     (93) 23,077  
(Decrease) increase in cash, cash equivalents, and restricted cash     (2,302) 228  
Effect of exchange rate changes on cash, cash equivalents, and restricted cash     10 (14)  
Cash, cash equivalents, and restricted cash, beginning of period     3,858 647  
Cash and cash equivalents, and restricted cash, end of period 1,566 861 1,566 861 3,858
Less: restricted cash at end of period 42 79 42 79  
Cash and cash equivalents $ 1,524 $ 782 1,524 782 $ 3,777
Supplemental Disclosures of Cash Flow Information          
Cash payments for interest     2,549 1,622  
Cash payments for income taxes, net of refunds     75 (153)  
Supplemental Disclosures of Non-Cash Investing and Financing Activities          
Capital expenditures in accounts payable and accrued liabilities     $ 817 270  
Deferred financing fees in accrued liabilities       $ 300